01 / Contract Profile
75A50124C00047 Federal Contract Award
Agency code 7505
SUPPLEMENTAL FUNDING FOR CLIN 0001; UPDATE THE POP FOR CLINS 0001 - 0007; UPDATE THE SOW AND MILESTONE TABLE ADVANCE THE DEVELOPMENT OF PAAG17G (DRUG PRODUCT: MIIST305), A ONCE DAILY, ORALLY ADMINISTERED, GUT-RESTRICTED DRUG, TO REDUCE MORTALITY A
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50124C00047 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$1.89M
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2024 | $16.94M | 2 | — |
| FY 2025 | $1.89M | 3 | −88.8% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
SYNEDGEN, INC.
UEI HX79BD6YQ521 · CAGE 5JGC8
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $18.83M | 5 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $18.83M | 5 | 100.0% |
08 / Place of Performance
Where is the work recorded?
CLAREMONT, LOS ANGELES, CALIFORNIA, UNITED STATES
ZIP 917113583
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Sep 26, 2025 | P00004 | $1.89M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN13 |
| Aug 19, 2025 | P00003 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN13 |
| Jan 10, 2025 | P00002 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN13 |
| Oct 31, 2024 | P00001 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN13 |
| Sep 26, 2024 | Base action | $16.94M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541715 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.